MNOV Collar Strategy
MNOV (MediciNova, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United States. Its robust development pipeline features MN-166 (ibudilast), an oral agent with both anti-inflammatory and neuroprotective properties, currently being investigated for a range of neurological conditions. These include primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and various forms of substance dependence and addiction. The company's portfolio also comprises MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist aimed at treating acute asthma attacks; MN-001 (tipelukast), an orally available small molecule designed for fibrotic disorders like nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent intended for solid tumor oncology. MediciNova has established strategic partnerships with companies such as Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Angiogene Pharmaceuticals Ltd., and Meiji Seika Kaisha Ltd. Established in 2000, the company's headquarters are situated in La Jolla, California.
MNOV (MediciNova, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $65.0M, a beta of 0.62 versus the broader market, a 52-week range of 1.17-1.96, average daily share volume of 34K, a public-listing history dating back to 2006, approximately 13 full-time employees. These structural characteristics shape how MNOV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.62 indicates MNOV has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a collar on MNOV?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current MNOV snapshot
As of June 30, 2026, spot at $1.33, ATM IV 20.80%, IV rank 0.12%, expected move 5.96%. The collar on MNOV below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this collar structure on MNOV specifically: IV regime affects collar pricing on both sides; compressed MNOV IV at 20.80% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 5.96% (roughly $0.08 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MNOV expiries trade a higher absolute premium for lower per-day decay. Position sizing on MNOV should anchor to the underlying notional of $1.33 per share and to the trader's directional view on MNOV stock.
MNOV collar setup
The MNOV collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MNOV near $1.33, the first option leg uses a $1.40 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MNOV chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MNOV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $1.33 | long |
| Sell 1 | Call | $1.40 | N/A |
| Buy 1 | Put | $1.26 | N/A |
MNOV collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
MNOV collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on MNOV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on MNOV
Collars on MNOV hedge an existing long MNOV stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
MNOV thesis for this collar
The market-implied 1-standard-deviation range for MNOV extends from approximately $1.25 on the downside to $1.41 on the upside. A MNOV collar hedges an existing long MNOV position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current MNOV IV rank near 0.12% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MNOV at 20.80%. As a Healthcare name, MNOV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MNOV-specific events.
MNOV collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MNOV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MNOV alongside the broader basket even when MNOV-specific fundamentals are unchanged. Always rebuild the position from current MNOV chain quotes before placing a trade.
Frequently asked questions
- What is a collar on MNOV?
- A collar on MNOV is the collar strategy applied to MNOV (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With MNOV stock trading near $1.33, the strikes shown on this page are snapped to the nearest listed MNOV chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MNOV collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the MNOV collar priced from the end-of-day chain at a 30-day expiry (ATM IV 20.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MNOV collar?
- The breakeven for the MNOV collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MNOV market-implied 1-standard-deviation expected move is approximately 5.96%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on MNOV?
- Collars on MNOV hedge an existing long MNOV stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current MNOV implied volatility affect this collar?
- MNOV ATM IV is at 20.80% with IV rank near 0.12%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.